The CenterWatch Weekly, August 22, 2016
Pharmaceutical Product Development (PPD) has agreed to buy Evidera, a Maryland-based company that provides evidence-based solutions for the healthcare industry, as demand rises for research that shows the effectiveness and value of new medicines in real world settings.
Charles River Laboratories is first CRO to join U.K.-based research consortium
Charles River Laboratories is the first full-service contract research organization (CRO) to join the U.K.-based, international Milner Therapeutics Institute and Consortium.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.